Lyra Therapeutics, Inc. (the Company or Lyra) announced the appointment of John Bishop, Ph.D., as Chief Technology Officer, effective February 27, 2023. Dr. Bishop will lead the commercial scale-up of Lyra's manufacturing operations for the Company's late-stage product candidates, LYR-210 and LYR-220.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.328 USD | -1.09% | +0.77% | -93.74% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-93.74% | 20M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- LYRA Stock
- News Lyra Therapeutics, Inc.
- Lyra Therapeutics, Inc. Announces Appointment of John Bishop as Chief Technology Officer